.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 4,695,590

« Back to Dashboard

Claims for Patent: 4,695,590

Title: Method for retarding aging
Abstract:Methods and compositions are provided for retarding aging, i.e., inhibiting damage to human cells caused by toxic byproducts of oxygen metabolism. The anti-aging active ingredient is a compound or mixture of compounds represented by the following structural formula: ##STR1## wherein m is 0, 1 or 2; n is 0 or 1; R1 is hydrogen, halogen or hydroxy; and R2 and R3 each independently represent hydrogen or methyl provided that when m is 0, n is 0 and when m is 1 or 2, n is 1 and R1 is hydroxy or halogen and that when m is 2, each R2 can be the same or different and each R3 can be the same or different or a pharmaceutically acceptable alkali or alkaline earth metal salt thereof.
Inventor(s): Lippman; Richard D. (Scottsdale, AZ)
Assignee: California Health Technologies (Los Angeles, CA)
Application Number:06/859,464
Patent Claims: 1. A method for retarding aging in humans by administering to a human a daily dosage of from about 0.5 mg per kilogram of body weight to less than about 2 mg per kilogram of body weight of a pharmaceutically acceptable composition comprising a compound or a mixture of compounds represented by the following structural formula: ##STR6## wherein m is 0, 1 or 2;

n is 0 or 1;

R1 is hydrogen, halogen or hydroxy; and

R2 and R3 each independently represents hydrogen or methyl provided that when m is 0, n is 0 and when m is 1 or 2, n is 1 and R1 is hydroxy or halogen and that when m is 2, each R2 can be the same or different and each R3 can be the same or different or

a pharmaceutically acceptable alkali or alkaline earth metal salt thereof.

2. The method according to claim 1 wherein the compound is nordihydroguairetic acid.

3. The method according to claim 1 wherein the compound is bis(p-hydroxyphenyl)methane.

4. The method according to claim 1 wherein the composition is administered orally.

5. The method according to claim 1 wherein the composition is administered by a means selected from the group consisting of intravenously, subcutaneously, intramuscularly and intracutaneously.

6. A pharmaceutical composition in solid dosage form for retarding aging in humans consisting essentially of a compound or mixture of compounds represented by the following structural formula as the active ingredient: ##STR7## wherein m is 0, 1 or 2;

n is 0 or 1;

R1 is hydrogen, halogen or hydroxy; and

R2 and R3 each independently represents hydrogen or methyl provided that when m is 0, n is 0 and when m is 1 or 2, n is 1 and R1 is hydroxy or halogen and that when m is 2, each R2 can be the same or different and each R3 can be the same or different or

a pharmaceutically acceptable alkali or alkaline earth metal salt thereof, wherein from about 20 mg to 100 mg of said active ingredient is present in the composition.

7. A composition as is claimed in claim 6 wherein the compound is nordihydroguairetic acid.

8. A composition as is claimed in claim 6 wherein the compound is bis(p-hydroxyphenyl)methane.

9. A pharmaceutical composition for topical administration to the skin of a human consisting essentially of an effective amount of a compound or mixture of compounds represented by the following structural formula as the only active ingredient in a topical pharmaceutically acceptable carrier: ##STR8## wherein m is 0, 1 or 2;

n is 0 or 1;

R1 is hydrogen, halogen or hydroxy; and

R2 and R3 each independently represents hydrogen or methyl provided that when m is 0, n is 0 and when m is 1 or 2, n is 1 and R1 is hydroxy or halogen and that when m is 2, each R2 can be the same or different and each R3 can be the same or different or

a pharmaceutically acceptable alkali or alkaline earth metal salt thereof.

10. A composition as is claimed in claim 9 wherein the compound is nordihydroguairetic acid.

11. A composition as is claimed in claim 9 wherein the compound is bis(p-hydroxyphenyl)methane.

12. A composition as is claimed in claim 10 wherein the composition contains from about 0.5% to about 20% by weight of nordihydroguairetic acid compared to the total weight of the composition.

13. A pharmaceutical composition for topical administration to the skin of a human consisting essentially of a compound or mixture of compounds represented by the following structural formula as the acitve ingredient in a topical pharmaceutically acceptable carrier, wherein the composition contains from about 0.5% to about 20% by weight of the active ingredient compared to the total weight of the composition: ##STR9## wherein m is 0, 1 or 2;

n is 0 or 1;

R1 is hydrogen, halogen or hydroxy; and

R2 andR3 each independently represents hydrogen or methyl provided that when m is 0, n is 0 and when m is 1 or 2, n is 1 and R1 is hydroxy or halogen and that when m is 2, each R2 can be the same or different and each R3 can be the same or different or

a pharmaceutically acceptable alkali or alkaline earth metal salt thereof.

14. A composition as is claimed in claim 13 wherein the compound is nordihydroguairetic acid.

15. A composition as is claimed in claim 13 wherein the compound is bis(p-hydroxyphenyl)methane.

16. A composition as is claimed in claim 14 wherein the composition contains from about 0.5% to about 20% by weight of nordihydroguairetic acid compared to the total weight of the composition.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc